SEC Filing Details

Document Details

Filing Date
Feb 5, 2024
Document Date
Feb 5, 2024
Form Description
SCHEDULE 13G - Description
Company
G1 Therapeutics, Inc.
Issuer
G1 Therapeutics, Inc.